Health ConditionsXerostomia, also known as dry mouth, is a subjective complaint of dryness in the mouth, which may be associated with a change in the composition of saliva, reduced salivary flow, or have no identifiable cause. The word itself derives from the Greek: xeros meaning "dry" and stoma meaning "mouth."
A clinically important distinction exists between the subjective symptom and an objective measurement of reduced output. Xerostomia is the subjective sensation of dry mouth and is the most common symptom of salivary gland hypofunction (SGH). Although it often reflects impaired salivary gland function, it can occur with or without a noticeable decrease in saliva production. In most circumstances, xerostomia is accompanied by SGH, which reflects an objective, measurable decrease in salivary flow (hyposalivation).
Objective thresholds have been defined. An unstimulated whole saliva flow rate in a normal person is 0.3–0.4 ml per minute, and below 0.1 ml per minute is considered significantly abnormal. A stimulated saliva flow rate less than 0.5 ml per gland in 5 minutes or less than 1 ml per gland in 10 minutes is considered decreased. In healthy individuals, salivary secretion averages 1,000 ml to 1,500 ml per day.
Xerostomia is not a disease, but it may be a symptom of various medical conditions, a side effect of radiation to the head and neck, or a side effect of a wide range of medications.
The hallmark symptom of xerostomia is a feeling of stickiness in the mouth due to a lack of saliva. A lack of normal salivary flow may lead to complaints of mouth dryness, oral burning, swallowing difficulty, and loss or decreased taste.
In more pronounced or chronic presentations, the oral consequences are wide-ranging. Xerostomia can lead to markedly increased dental caries, parotid gland enlargement, inflammation and fissuring of the lips (cheilitis), inflammation or ulcers of the tongue and buccal mucosa, oral candidiasis, salivary gland infection (sialadenitis), halitosis, and cracking and fissuring of the oral mucosa.
Patients with xerostomia often complain of taste disorders (dysgeusia), a painful tongue (glossodynia), and an increased need to drink water, especially at night. In persons with Sjögren's syndrome, xerostomia can have a severe impact as patients find eating, speaking, swallowing, and sleeping difficult. Oral symptoms include soreness, adherence of food to the mucosa, dysgeusia, and dysphagia. Oral signs include a lobulated or depapillated red tongue and angular cheilitis.
Xerostomia is often a contributing factor for both minor and serious health problems. It can affect nutrition and dental, as well as psychological, health. Nutritional consequences are documented: the parched, crusty, and sensitive conditions dry mouth creates can hamper the ability to tolerate spicy or acidic foods. Other foods, such as breads, cereals, and some fruits and vegetables, can be difficult to chew and swallow because of a lack of saliva to moisten them. People with dry mouth often perceive the taste and quality of their food to be poor in general, which curbs appetite and blunts overall interest in eating.
The salivary submandibular, parotid, sublingual, and submucosal glands produce saliva, which is necessary for the moistening of food products, breakdown of carbohydrates by salivary amylase, antimicrobial and other protective mechanisms. The basic secretory units of salivary glands are clusters of acini cells. Saliva is a fluid that contains water, electrolytes, mucus, and enzymes, all of which flow out of the acinus into collecting ducts.
Beyond its primary constituents of water and electrolytes, saliva contains a rich repertoire of proteins, enzymes, mucins, and immunoglobulins that contribute to its lubricating, digestive, and antimicrobial properties. More than 1,000 proteins have been identified in saliva, with these having several biological and antimicrobial functions that influence numerous aspects of oral health, food digestion, and taste.
Key functional roles include:
Xerostomia may result from reduced salivary flow (hyposalivation), altered salivary composition, or impaired autonomic regulation of salivary secretion. It is most commonly caused by medications, particularly those with anticholinergic properties, such as antidepressants and drugs for urinary incontinence. Medications are a common cause of xerostomia, with drugs for urinary urge incontinence and antidepressant medications at the top of the list, presumably due to disruption of parasympathetic signaling pathways.
Reduced salivary secretion disrupts the normal protective and digestive functions of saliva, leading to impaired buffering, reduced antimicrobial activity, altered taste, and difficulties with mastication and swallowing.
Dry mouth is common, affecting about 1 in 5 people. Risk for dry mouth increases with age. Prevalence is at least 20% in the general population, with increased prevalence in females (up to 30%).
In older populations, the figures are markedly higher. The incidence of xerostomia ranges from 0.9 to 64.8% in the general population and occurs in approximately 30% of adults over 65 years of age and 40% of adults over 80 years of age. The incidence is higher in the geriatric population than in younger adults. A longitudinal study in Sweden revealed that xerostomia was significantly more prevalent in women than in men across all age groups. At the age of 80 years, "often mouth dryness at night" was reported by 24.3% of women and 16.2% of men.
In register-based research, female gender, polypharmacy, and age above 71 years were associated with the highest prevalence of xerostomia.
Drugs are the most common cause of xerostomia; about 400 prescription medications and many over-the-counter (OTC) medications cause decreased salivation. Common drug classes that cause xerostomia include antihypertensives, anxiolytics, and antidepressants (less severe with selective serotonin reuptake inhibitors [SSRIs] than with tricyclics).
Cardiovascular medications in hospitalized elderly patients and respiratory diseases in the elderly outpatients are the main factors for xerostomia, but the use of psychiatric drugs is also the strongest explanatory factor for all patients. The most common medication types with the highest prevalence of associated xerostomia include antihistamines (66.66%), psychotherapeutic medications (60%), pain medications (55.88%), endocrinologic agents (51.21%), antidyslipidic agents (50%), and antihypertensive medications (38.98%).
Sjögren's syndrome is a chronic systemic autoimmune disease characterized by lymphocytic infiltration of exocrine glands. It can present as an entity by itself (primary Sjögren's syndrome) or in addition to another autoimmune disease (secondary Sjögren's syndrome). Primary Sjögren's syndrome has a strong female propensity and is more prevalent in Caucasian women, with the mean age of onset usually in the 4th to 5th decade.
The female-to-male ratio of Sjögren's syndrome is 9:1. It can affect individuals of any age but is most common in elderly people. Onset typically occurs in the fifth to sixth decade of life.
Other systemic diseases that can cause xerostomia include rheumatoid arthritis, systemic lupus erythematosus, scleroderma, diabetes mellitus, hypertension, cystic fibrosis, bone marrow transplantation, endocrine disorders, nutritional deficiencies, nephritis, thyroid dysfunction, and neurological diseases such as Bell's palsy and cerebral palsy.
In cross-sectional research, elderly people with diabetes had significantly higher odds of having self-reported xerostomia (OR: 3.59; 95% CI: 1.48–8.68; P < 0.001), as did those who had chronic diseases and used continuous medication (OR: 2.3; 95% CI: 1.19–4.67; P = 0.009).
Xerostomia is mainly caused by radiation and chemotherapy, various systemic and autoimmune diseases, and drugs. Chemotherapeutic agents cause severe dryness and stomatitis while they are being taken; these problems usually end after therapy is stopped. Radiation-induced damage is typically more lasting because of direct injury to glandular tissue.
Dehydration resulting from impaired water intake, emesis, diarrhea, or polyuria can result in xerostomia. Occasional dry mouth is normal; for instance, the mouth gets dry when dehydrated.
Psychogenic causes such as depression, anxiety, stress, or fear can result in xerostomia. Alzheimer's disease or stroke may alter the ability to perceive oral sensations. Mental fatigue or stress under complicated environments in social life is also known to bring on dry mouth.
From a dietary perspective, caffeine is the most commonly identified dietary contributor to xerostomia. Alcohol consumption is a common modifying factor. Dry mouth is often exacerbated by activities such as hyperventilation, breathing through the mouth, smoking, or drinking alcohol. Risk factors include polypharmacy and tobacco and alcohol use.
Other causes of acute or chronic reduced salivary flow include mechanical blockage, infection of the salivary glands, anemia, local surgery, damage to the innervation (nerves) of the salivary glands, connective tissue diseases (e.g., scleroderma), Sjögren syndrome, sarcoidosis, radiation therapy of the head or neck, chemotherapy, immunotherapy, emotional stress, and congenital factors (e.g., ectodermal dysplasia).
There is a bidirectional relationship between xerostomia and nutritional status. Impaired saliva flow reduces food tolerance, which can in turn worsen nutritional adequacy. Research has noted that senior citizens with dry mouth were eating foods lower in 12 nutrients ranging from vitamin A to thiamin compared with a group without the problem. Particularly lacking in their diets were potassium, vitamin B6, iron, calcium, and zinc, as well as fiber.
Specific nutritional associations discussed in the literature include:
These associations are observational; while nutrient deficiencies may accompany xerostomia, a direct causal role for nutritional repletion reversing xerostomia has not been robustly established in controlled human trials.
The following entries separate traditional use from available scientific evidence, with explicit characterization of evidence quality.
Traditional and Historical Use: Malic acid is a naturally occurring organic acid found in tart fruits such as apples and unripe grapes. Its sialogogue (saliva-stimulating) properties have been recognized empirically in folk practice through the consumption of sour foods to stimulate saliva flow.
Scientific Evidence: Malic acid has been the subject of several randomized controlled trials (RCTs) in the context of drug-induced and idiopathic xerostomia. Salivary stimulants containing acidic substances such as citric and malic acids are used to stimulate glandular secretion. These sialagogues are often enriched with sodium fluoride or xylitol to reduce the risk of demineralization by lowering saliva pH.
Unstimulated and stimulated salivary flow rates were measured before and after application in clinical studies, and the results demonstrated that malic acid improved xerostomia and the production of saliva compared to the placebo group. A systematic review and meta-analysis confirmed this: more salivary flow was measured in the malic acid group than the placebo spray group (MD = 0.06; 95% CI: 0.03 to 0.09) across five studies.
In one RCT comparing a 1% malic acid spray to a betaine-based mouthwash: all three groups (malic acid, betaine-based mouthwash, and placebo) reported significant improvement in the dry mouth sensation and non-stimulated salivary flow rates, but only the malic acid spray and the betaine-based mouthwash significantly improved oral-health-related quality of life. There were no significant differences between both intervention groups.
Evidence strength: Multiple RCTs and a meta-analysis support short-term symptomatic improvement and modest increases in salivary flow with 1% topical malic acid. Evidence is considered moderate to good for short-term use in drug-induced and idiopathic xerostomia, though long-term data are limited.
Traditional and Historical Use: Chewing of fibrous or stimulating foods to promote saliva flow is a near-universal folk practice. Sugar-free chewing gum, often containing xylitol derived from plant sources (birch, beech, corn), has been widely used as a salivary stimulant.
Scientific Evidence: A systematic review and meta-analysis published in BMC Oral Health (2023) examined 25 papers on gum chewing in xerostomia. Of the 25 papers, six met the criteria for meta-analysis, which confirmed a significant overall effect of gum on saliva flow outcomes compared to control (SMD = 0.44, 95% CI: 0.22–0.66; p = 0.00008; I² = 46.53%). Chewing gum can increase unstimulated salivary flow rate in elderly and medically compromised people with xerostomia. Increasing the number of days over which gum is chewed increases the improvement in the rate of salivation. Gum chewing is linked with improvements in self-reported levels of xerostomia, although no significant effects were detected in five of the studies reviewed.
Evidence strength: Moderate evidence from meta-analysis supports mechanical salivary stimulation via chewing gum. Results are heterogeneous across studies, likely reflecting differing gum types, populations, and outcome measures.
Traditional Use: Chamomile has been used in European folk medicine and by traditional herbalists for centuries as an anti-inflammatory, soothing, and wound-healing agent for mucous membranes. Infusions and mouthwashes prepared from chamomile flowers are documented in traditional botanical practice throughout Central and Eastern Europe for oral discomfort and mucosal inflammation.
Scientific Evidence: Traditional medicine, through the administration of different medicinal herbs and plants, has recently been evaluated against xerostomia in clinical trials. Matricaria chamomilla L., Linum usitatissimum, and Malva sylvestris L. together with Althea digitata Boiss, licorice root, and Salvia officinalis are among the most used compounds.
A chamomile and linseed saliva substitute, prepared as aqueous extracts, positively affected four out of five xerostomia symptoms, while the conventional saliva substitute only impacted two of them. In clinical trials involving head and neck cancer patients undergoing radiation or chemotherapy and experiencing irritation of the oral mucosa, the administration of chamomile mouthwash offered relief from oral discomfort. Furthermore, patients' clinical signs of mucositis disappeared within the initial week of using the mouthwash.
Evidence strength: Preliminary. The number of clinical evaluations is small, and most involve chamomile in combination with other plant extracts. The low number of clinical evaluations represents the greatest limitation for validating the efficacy of traditional medicine against xerostomia.
Traditional Use: Flaxseed mucilage — the viscous, gel-forming polysaccharide extracted from the seed coat — has been used in traditional European and Middle Eastern herbal medicine as a demulcent (a substance that forms a soothing film over mucous membranes). Linseed tea and preparations were applied to relieve irritation and dryness of the mouth and throat.
Scientific Evidence: A chamomile and linseed saliva substitute positively affected four out of five xerostomia symptoms, while the conventional saliva substitute only impacted two of them. Participants were asked to evaluate their sense of relief from xerostomia symptoms when using each substitute on a scale from 1 to 10. The chamomile and linseed saliva substitute provided greater relief for three of the five symptoms than the conventional substitute.
A review study found that a combination of Malva sylvestris and Alcea digitata, lycopene-enriched virgin olive oil, a combination of Matricaria chamomilla and Linum usitatissimum, Althaea officinalis, and licorice improved xerostomia-related symptoms and enhanced patient quality of life.
Evidence strength: Preliminary. Most evidence comes from small comparative trials using combined herbal preparations rather than isolated flaxseed interventions.
Traditional Use: Malva sylvestris L. and Alcea digitata have been employed in traditional Persian medicinal practices for their cough suppressant, antioxidant, expectorant, anti-inflammatory, antimicrobial, and laxative properties. Similarly, marshmallow root (Althaea officinalis), from the same Malvaceae family, has a long history in European and Islamic traditional medicine as a demulcent and emollient agent for mucosal dryness and irritation, with mucilage (composed of polysaccharides) as its principal active fraction.
Scientific Evidence: A study conducted by Ameri et al. (2016) assessed the effectiveness of an herbal mixture containing Malva sylvestris and Alcea digitata in treating radiation-induced xerostomia in a cohort of 62 patients contrasting it with Hypozalix (control treatment) in a randomized clinical trial. Both the herbal mixture and Hypozalix positively affected symptoms of dry mouth. A 2025 RCT of a Malva sylvestris mouthwash in chemotherapy-induced stomatitis found that although the mean stomatitis score remained lower in the intervention group on day 14, the difference was no longer statistically significant (P = 0.07).
Evidence strength: Limited. Results from small RCTs are mixed or not statistically significant. The demulcent mechanism (coating and lubricating oral mucosa) is biologically plausible, but robust efficacy data are lacking.
Traditional Use: Licorice root has been used for thousands of years in traditional Chinese medicine, Ayurveda, and traditional European phytotherapy. Preparations include decoctions, chewing of the dried root, and extracts applied directly to oral mucosa for dryness, inflammation, and soothing of the throat and digestive tract. In traditional Chinese medicine, licorice (Gan Cao) is considered a "harmonizing" herb used to moisten dryness and replenish yin.
Scientific Evidence: Licorice root appears in review-level summaries of plant-based xerostomia interventions. Licorice root is among the most-used compounds in traditional medicine evaluated against xerostomia in clinical trials. A review found that licorice improved xerostomia-related symptoms and enhanced patient quality of life.
Evidence strength: Preliminary. Licorice root has been incorporated into formulations evaluated in small clinical studies, with generally positive symptomatic findings, but independent high-quality RCTs specifically isolating licorice are not yet available in the literature accessed.
Traditional Use: Sage has a documented history of use in Mediterranean folk medicine as a mouthwash and gargle for oral inflammation, dryness, and as an astringent. In traditional European herbal practice it was prepared as a tea for sore or dry mouth.
Scientific Evidence: Salvia officinalis is among the most-used plant compounds evaluated in clinical trials against xerostomia. It appears primarily in combination formulations. These preparations were formulated as water extracts with health benefits attributed to the presence of polyphenols. Isolated clinical data on sage as a single intervention for xerostomia in human trials remain sparse.
Evidence strength: Insufficient for independent conclusions. Sage's polyphenol content provides a plausible anti-inflammatory rationale, but single-agent clinical evidence in xerostomia is preliminary.
Traditional Use: In Traditional Chinese Medicine (TCM), dry mouth is frequently interpreted as a manifestation of yin deficiency or insufficiency of body fluids (jin ye). TCM practitioners may describe these symptoms as "yin deficiency." Depending on the person and the cause of dry mouth, specific combinations of herbs — including but not limited to American ginseng and Asian ginseng — can help nourish "yin" to restore balance in the body and generate fluids.
Among the most popular herbs and herbal formulas in TCM for this indication are Ren-Shen (Ginseng), Huang-Qi (Astragali Radix), Dang-Gui (Angelica sinensis), Hong-Jing-Tian (Rhodiolae Crenulatae Radix), Gou-Qi-Zi (the fruit of Chinese wolfberry), Sha-Shen (Adenophora stricta), and classical Chinese herbal compound formulas for nourishing Qi and Blood such as "Si-Wu-Tang," "Si-Jun-Zi-Tang," and "Bu-Zhong-Yi-Qi-Wan."
Scientific Evidence: Herbal medicines have shown potential benefits for improving salivary function and reducing the severity of dry mouth in patients. However, methodological limitations and a relatively small sample size reduced the strength of the evidence.
Evidence strength: Preliminary. Evidence derives primarily from small, often unblinded trials or pilot studies. Methodological heterogeneity and limited sample sizes prevent firm conclusions.
Traditional Use: Acupuncture has been used in TCM for centuries for conditions attributed to yin deficiency, including dryness of body tissues. Specific acupoints are selected to "replenish Qi, nourish Yin, promoting blood circulation to remove meridian obstruction, and clear away heat" in cases of dry mouth, particularly after radiotherapy.
Scientific Evidence: Clinical trials and systematic reviews have been published on acupuncture for radiation-induced and other forms of xerostomia. A Cochrane-associated systematic review reported: Meta-analysis of unstimulated whole saliva data from three trials showed a very small effect favouring acupuncture, which is unlikely to be clinically important (mean difference: 0.02 ml/minute; 95% CI: 0 to 0.04; P = 0.04; I² = 57%). Heterogeneity is likely due to the different reasons for dry mouth in participants in these trials.
Regarding acupuncture, it did not show significant effects in the trials in comparison to the control groups. A study published in the Journal of Clinical Oncology (2010) showed that people who developed xerostomia after radiation for head and neck cancers experienced lasting relief from acupuncture as opposed to painkillers and other traditional medicines, and those with the most severe mouth dryness tended to have the greatest improvement.
Evidence strength: Mixed to weak. Meta-analysis does not demonstrate clinically meaningful benefit over control. Individual positive trial results exist (especially in radiation-induced xerostomia), but overall evidence is insufficient to support a definitive recommendation.
Traditional and Dietary Context: Omega-3 fatty acids (particularly EPA and DHA from fish oil, and ALA from flaxseed oil) are established dietary anti-inflammatory nutrients. Their potential relevance to xerostomia relates to the inflammatory pathology underlying conditions such as Sjögren's syndrome.
Scientific Evidence: Results from clinical trials are mixed. A prospective, randomized, double-masked, placebo-controlled trial in Sjögren's patients found: the unstimulated salivary flow for the omega-3 group was 0.069 ± 0.082 ml/min at baseline and was significantly improved at 3 months to 0.115 ± 0.12 ml/min (p = 0.029). The unstimulated salivary flow for the placebo group improved from 0.042 to 0.045 ml/min (not significant).
However, a separate pilot study found conflicting results: the differences between the omega-3 group and wheat germ oil group were not statistically significant for either unstimulated or stimulated salivary secretion (p = 0.38 and p = 0.346, respectively). Supplementation with omega-3 was not found to be significantly better than wheat germ oil in stimulating saliva production in patients with Sjögren's syndrome.
A systematic review on dietary interventions in Sjögren's disease noted: an omega-3 fatty acid supplement containing flaxseed oil, fish oil, and vitamin E may allow for improvement in symptoms of dry mouth, increased salivary gland secretion, and arrest of gingival inflammation. However, the review also concluded: the impact of nutritional interventions on Sjögren's disease remains uncertain, and no standardized guidelines currently exist for managing its sicca symptoms.
Evidence strength: Mixed. Two small RCTs produced contradictory results. Evidence is insufficient to recommend omega-3 supplementation specifically for xerostomia management, though the anti-inflammatory rationale in autoimmune-driven xerostomia is biologically plausible.
Adequate fluid intake is foundational to oral hydration. Often overlooked, insufficient fluid intake or excessive sweating can lead to dry mouth. Regular water sipping is explicitly included in clinical management guidelines as a first-line supportive measure. Initial management includes patient education, such as regular water sipping and avoiding tobacco smoking, as well as local measures such as artificial saliva.
From a dietary perspective, caffeine is the most commonly identified contributor to xerostomia. Alcohol consumption is a common modifying factor. Both substances are diuretic or dehydrating and can reduce salivary output.
Dry mouth is often exacerbated by smoking. Tobacco use is documented among the lifestyle risk factors for xerostomia in multiple epidemiological reviews.
Breathing through the mouth or snoring can dry out the mouth during sleep or prolonged periods of inactivity. This mechanical cause does not reflect salivary gland dysfunction per se but produces the same subjective symptom and oral consequences.
As noted above, xerostomia has a bidirectional relationship with dietary intake. The parched, crusty, and sensitive conditions dry mouth creates can hamper the ability to tolerate spicy or acidic foods. Other foods such as breads, cereals, and some fruits and vegetables can also be difficult to chew and swallow because of a lack of saliva to moisten them. Over time, these restrictions lead to nutrient shortfalls — particularly in fiber, B vitamins, potassium, zinc, and calcium — creating a secondary nutritional burden.
Patients often struggle with social withdrawal, economic burden, and poor nutrition as a result of their difficulty eating. Chronic xerostomia significantly increases the risk of experiencing dental caries, demineralization, tooth sensitivity, candidiasis, and other oral diseases that may affect quality of life negatively. The prevalence of Candida albicans may be as high as 68% in patients with Sjögren's syndrome.
Allantoin is incorporated in the betaine–allantoin (Xeros Dentaid) saliva substitute mouthwash clinically validated for xerostomia. A randomized controlled trial (n=51) found this formulation was comparable to 1% malic acid spray in significantly improving dry mouth sensation and oral health-related quality of life in drug-induced and idiopathic xerostomia.
Multiple clinical trials have evaluated aloe vera for xerostomia. A triple-blind RCT in 105 diabetic patients (Badooei et al., 2021) found that a 20 mL aloe vera mouthwash used three times daily for 14 days significantly reduced all xerostomia symptoms compared to saline. A separate triple-blind RCT in ICU patients found an aloe vera/peppermint gel (Veramin) significantly reduced mouth dryness and improved oral health.
Chamomile (Matricaria chamomilla) combined with linseed extract was evaluated in a double-blind RCT of 74 elderly xerostomia patients, showing significant improvements in dry mouth, thick saliva, and swallowing difficulty versus carboxymethylcellulose control. Chamomile mouthwash has also provided oral mucositis relief in head and neck cancer patients undergoing radiation therapy.
Coconut oil was evaluated in a primary feasibility study for radiation-induced xerostomia at Ottawa Hospital Cancer Centre, demonstrating feasibility and subjective dry mouth relief. A crossover RCT in Sjögren's syndrome patients compared coconut oil to aloe vera and found both effective for dry mouth management. Coconut oil's lubricating fatty acids coat oral mucosal surfaces.
EGCG, the principal active catechin in green tea, is the key constituent in MighTeaFlow, a clinically validated xerostomia formula. Research at the Dental College of Georgia found EGCG may partially restore salivary gland function and delay progression of salivary gland dysfunction through molecular and cellular mechanisms in gland acinar cells.
Linseed (flaxseed) extract Salinum® was compared to sodium carboxymethyl cellulose in a crossover study of 20 radiation-induced xerostomia patients, with both providing beneficial dry mouth symptom relief. A subsequent double-blind RCT confirmed a chamomile-linseed combination significantly improved dry mouth, thick saliva, and swallowing difficulty versus carboxymethylcellulose in 74 elderly patients.
Ginger has been clinically evaluated as a sialagogue for xerostomia. A triple-blind RCT in 105 diabetic patients showed ginger mouthwash (20 mL, 3× daily for 14 days) produced the most pronounced reduction in xerostomia symptoms compared to aloe vera and saline. Its mechanism involves parasympathetic stimulation via muscarinic M3 receptors.
Korean red ginseng (KRG) has been evaluated in a double-blind RCT (n=100) for dry mouth. While the overall population showed no significant benefit, subgroup analysis found KRG significantly improved dry mouth VAS in menopausal women (ages 40–59) at 4 and 8 weeks. TCM also uses American and Asian ginseng to nourish yin and restore fluid generation in dry mouth.
Green tea catechins, particularly EGCG, were evaluated in a double-blind placebo-controlled Phase II RCT (MighTeaFlow formula, 60 xerostomia patients) and found to significantly improve stimulated whole salivary flow rate versus placebo. Preclinical research suggests EGCG may delay salivary gland dysfunction and partially restore salivary gland function through molecular mechanisms.
Thyme honey oral rinse was evaluated in a single-blind RCT of 28 geriatric ESRD patients with xerostomia, significantly improving subjective and objective dry mouth scores, salivary flow rate, and salivary pH versus saline. A 2025 BMC Oral Health RCT demonstrated Manuka honey rinse significantly improved xerostomia, salivary flow, and quality of life in elderly adults.
Multiple clinical trials have evaluated LPO-containing oral hygiene products (toothpastes, mouthwashes, gels) for xerostomia relief. Products mimicking the natural salivary antimicrobial system improved subjective dry mouth symptoms and some clinical signs in elderly and medicated patients. Tenovuo (2002) reviewed evidence for use of salivary antimicrobial proteins including LPO in xerostomia management, noting their incorporation into oral care products to restore saliva's antimicrobial capacity.
Fermented lingonberry juice (FLJ) has been identified in a 2025 Inflammopharmacology peer-reviewed review as a natural agent that enhances salivary pH and stimulates salivation, positioning it as a candidate therapeutic for xerostomia management. Lingonberry's organic acids and polyphenols are proposed to activate gustatory receptors and support salivary gland function.
Lycium barbarum polysaccharides (LBP) have been shown in Sjögren's syndrome animal models to promote salivation, stimulate salivary flow, and reduce inflammatory responses in salivary gland tissue. The 2025 Inflammopharmacology review positions LBP as a viable treatment option for xerostomia. In TCM, Lycium (Gou Qi Zi) is used to nourish yin and restore oral moisture.
Lycopene combined with virgin olive oil in spray form was tested in a double-blind RCT of 60 elderly patients with drug-induced xerostomia over 12 weeks. The treatment group showed significant improvement in specific Xerostomia Inventory domains. Lycopene's proposed role is antioxidant protection of oral mucosal and salivary gland tissues.
Malva sylvestris, a mucilaginous plant used in traditional Persian medicine for dry mouth, was evaluated in a randomized clinical trial of 62 head and neck cancer patients. The herbal compound (with Alcea digitata) significantly reduced xerostomia grade versus artificial saliva (Hypozalix), and a follow-up RCT showed improved quality of life in radiation-induced xerostomia patients.
Animal (porcine gastric) mucin is used in saliva substitute formulations such as Saliva Orthana for xerostomia. An objective tribological study found mucin-containing substitutes were among only a few biopolymers outperforming water in oral lubrication by adsorbing to the salivary conditioning film, closely mimicking native salivary mucin boundary lubrication.
Lycopene-enriched virgin olive oil spray was evaluated in a double-blind RCT of 60 elderly patients with drug-induced xerostomia over 12 weeks. The treatment group showed significant improvements in speaking difficulty, perceived saliva amount, and lip dryness on the Xerostomia Inventory, though resting salivary flow rate did not change. Olive oil's lubricating fatty acid composition provides oral coating.
Promoting fluid secretion and relieving dry mouth is one of the most ancient and consistently documented uses of ophiopogon root across TCM, Kampo, and the Chinese Pharmacopoeia. Preclinical research shows polysaccharides possess preventive effects in a Sjögren's syndrome animal model — the autoimmune condition causing pathological dry mouth. The Japanese Pharmacopoeia (16th edition) lists dry mouth-related indications.
Peppermint essential oil (3%) combined with aloe vera jelly in Veramin moisturizing gel was tested in a triple-blind RCT of 80 ICU patients with xerostomia. The gel significantly reduced mouth dryness, prevented dental plaque formation, and improved oral health versus placebo. Peppermint's cooling receptor (TRPM8) stimulation may also mask dry mouth perception.
Yohimbine has clinical evidence supporting its use as a sialogogue (saliva stimulant), particularly for drug-induced xerostomia. Placebo-controlled trials demonstrate it significantly increases salivary secretion in healthy volunteers and in patients on psychotropic drugs. It works by blocking α2-adrenoceptors on salivary gland nerve pathways and by activating cholinergic mechanisms.
Adenophora (Sha-Shen in TCM) is classified as a fluid-generating, yin-nourishing herb in traditional Chinese medicine prescribed for dry mouth, dry throat, and thirst. A 2022 Fortunejournals clinical management review lists Sha-Shen among the herbs used for radiation-induced xerostomia, commonly paired with Ophiopogon in TCM fluid-generating formulas.
Astragalus (Huang-Qi in TCM) is among the most commonly prescribed herbs in TCM formulas for radiation-induced xerostomia and salivary gland recovery, as documented in a 2022 Fortunejournals clinical management review. TCM formulas containing Astragalus have been evaluated in RCTs for xerostomia in cancer patients and shown potential benefits for improving salivary function.
Ophiopogon japonicus (Mai-Dong in TCM) is a core yin-nourishing herb in traditional Chinese medicine prescribed specifically to generate fluids and relieve dry mouth. It appears in classical formulas for Sjögren's syndrome dry mouth and in a Chinese herbal mix evaluated in clinical reviews as effective for dry mouth in cancer patients.
Prickly ash has long been classified as a sialagogue — an agent that promotes saliva production — in traditional North American herbalism. Historical sources describe 'remarkable sialagogue properties, inducing a copious flow of saliva.' This action is attributed to the intense sensory stimulation of oral mucosa triggering reflex salivary secretion, making it a traditional remedy for xerostomia. No clinical human trials confirm this effect.
Rehmannia glutinosa (Sheng-Di-Huang in TCM) is the principal herb in classical yin-nourishing formulas used for dry mouth. It is the primary component of Yukmijihwang-tang, evaluated in a registered double-blind placebo-controlled RCT for xerostomia, and is listed as a core prescription herb for Sjögren's syndrome dry mouth treatment in TCM clinical reviews.
Go back